Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 297

    1.

    Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis.

    Troelsen LN, Garred P, Christiansen B, Torp-Pedersen C, Christensen IJ, Narvestad E, Jacobsen S.

    Mol Immunol. 2009 Nov 23. [Epub ahead of print]PMID: 19939454 [PubMed - as supplied by publisher]Related articles

    2.

    Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.

    Fosbøl EL, Gislason GH, Poulsen HE, Hansen ML, Folke F, Schramm TK, Olesen JB, Bretler DM, Abildstrøm SZ, Sørensen R, Hvelplund A, Køber L, Torp-Pedersen C.

    Circ Heart Fail. 2009 Nov;2(6):582-90. Epub 2009 Sep 22.PMID: 19919983 [PubMed - in process]Related articles

    3.

    Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population.

    Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.

    J Hypertens. 2009 Dec;27(12):2351-7.PMID: 19915482 [PubMed - in process]Related articles

    4.

    Predictors of right ventricular function as measured by tricuspid annular plane systolic excursion in heart failure.

    Kjaergaard J, Iversen KK, Akkan D, Møller JE, Køber LV, Torp-Pedersen C, Hassager C.

    Cardiovasc Ultrasound. 2009 Nov 4;7:51.PMID: 19889228 [PubMed - in process]Related articlesFree article

    5.

    Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure.

    Andersson C, Weeke P, Pecini R, Kjaergaard J, Hassager C, Køber L, Torp-Pedersen C.

    Scand Cardiovasc J. 2009 Nov 2. [Epub ahead of print]PMID: 19878095 [PubMed - as supplied by publisher]Related articles

    6.

    The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy.

    Møller DV, Pham TT, Gustafsson F, Hedley P, Ersbøll MK, Bundgaard H, Andersen CB, Torp-Pedersen C, Køber L, Christiansen M.

    Eur J Heart Fail. 2009 Nov;11(11):1031-5. No abstract available. PMID: 19875404 [PubMed - in process]Related articles

    7.

    Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial.

    Andersson C, Weeke P, Brendorp B, Køber L, Fosbøl EL, Sharma AM, Finer N, Caterson ID, Rode RA, James PT, Torp-Pedersen C.

    Nutr Metab (Lond). 2009 Oct 14;6:42.PMID: 19828038 [PubMed - in process]Related articlesFree article

    8.

    Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period.

    Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A, Torp-Pedersen C, Sharma AM, Ge H, Santoro D, Shepherd G, James P; ; for The SCOUT Investigators.

    Obesity (Silver Spring). 2009 Oct 8. [Epub ahead of print]PMID: 19816415 [PubMed - as supplied by publisher]Related articles

    9.

    Vernakalant (RSD1235) in the management of atrial fibrillation: a review of pharmacological properties, clinical efficacy and safety.

    Weeke P, Andersson C, Brendorp B, Torp-Pedersen C.

    Future Cardiol. 2008 Nov;4(6):559-67.PMID: 19804350 [PubMed - in process]Related articles

    10.

    Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.

    Van Gaal LF, Caterson ID, Coutinho W, Finer N, Maggioni AP, Sharma AM, Torp-Pedersen C, Ge H, Moran SA, Shepherd GM, James WP; on behalf of the SCOUT Investigators.

    Diabetes Obes Metab. 2009 Sep 16. [Epub ahead of print]PMID: 19758358 [PubMed - as supplied by publisher]Related articles

    11.

    Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH; ATHENA Investigators.

    Circulation. 2009 Sep 29;120(13):1174-80. Epub 2009 Sep 14.PMID: 19752319 [PubMed - indexed for MEDLINE]Related articles

    12.

    Systolic heart failure: a prothrombotic state.

    de Peuter OR, Kok WE, Torp-Pedersen C, Büller HR, Kamphuisen PW.

    Semin Thromb Hemost. 2009 Jul;35(5):497-504. Epub 2009 Sep 8.PMID: 19739040 [PubMed - in process]Related articles

    13.

    Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways.

    Palsgaard J, Brøns C, Friedrichsen M, Dominguez H, Jensen M, Storgaard H, Spohr C, Torp-Pedersen C, Borup R, De Meyts P, Vaag A.

    PLoS One. 2009 Aug 11;4(8):e6575.PMID: 19668377 [PubMed - in process]Related articlesFree article

    14.

    Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations.

    Folke F, Lippert FK, Nielsen SL, Gislason GH, Hansen ML, Schramm TK, Sørensen R, Fosbøl EL, Andersen SS, Rasmussen S, Køber L, Torp-Pedersen C.

    Circulation. 2009 Aug 11;120(6):510-7. Epub 2009 Jul 27.PMID: 19635969 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure.

    Kjekshus JK, Torp-Pedersen C, Gullestad L, Køber L, Edvardsen T, Olsen IC, Sjaastad I, Qvigstad E, Skomedal T, Osnes JB, Levy FO.

    Eur J Heart Fail. 2009 Aug;11(8):771-8. Epub 2009 Jun 30.PMID: 19567409 [PubMed - in process]Related articles

    16.

    Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide -Three new Cardiovascular Risk Markers -Do They Improve Risk Prediction and Influence Treatment?

    Olsen MH, Sehestedt T, Lyngbæk S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H.

    Curr Vasc Pharmacol. 2010 Jan 1. [Epub ahead of print]PMID: 19485906 [PubMed - as supplied by publisher]Related articles

    17.

    Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

    Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C; SCOUT Executive Steering Committee; SCOUT investigators.

    Metabolism. 2009 Aug;58(8):1109-15. Epub 2009 Jun 18.PMID: 19454355 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

    Andersen SS, Hansen ML, Gislason GH, Schramm TK, Folke F, Fosbøl E, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C.

    Europace. 2009 Jul;11(7):886-91. Epub 2009 May 14.PMID: 19443433 [PubMed - indexed for MEDLINE]Related articles

    19.

    Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

    Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.

    J Hypertens. 2009 Jun;27(6):1165-71.PMID: 19387364 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of dronedarone on cardiovascular events in atrial fibrillation.

    Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators.

    N Engl J Med. 2009 Feb 12;360(7):668-78. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. PMID: 19213680 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

    Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C.

    Arch Intern Med. 2009 Jan 26;169(2):141-9.PMID: 19171810 [PubMed - indexed for MEDLINE]Related articles

    22.

    Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.

    Levy WC, Mozaffarian D, Linker DT, Kenyon KW, Cleland JG, Komajda M, Remme WJ, Torp-Pedersen C, Metra M, Poole-Wilson PA; COMET Investigators.

    Eur J Heart Fail. 2009 Mar;11(3):256-63. Epub 2009 Jan 22.PMID: 19164422 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation.

    Hansen ML, Gadsbøll N, Rasmussen S, Gislason GH, Folke F, Andersen SS, Schramm TK, Sørensen R, Fosbøl EL, Abildstrøm SZ, Madsen M, Poulsen HE, Køber L, Torp-Pedersen C.

    J Intern Med. 2009 Mar;265(3):335-44.PMID: 19141096 [PubMed - indexed for MEDLINE]Related articles

    24.

    Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: The DIAMOND study.

    Fosbøl EL, Seibæk M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L; for the Danish Investigations and Arrhythmia ON Dofetilide (DIAMOND) study group.

    Int J Cardiol. 2008 Dec 16. [Epub ahead of print]PMID: 19095316 [PubMed - as supplied by publisher]Related articles

    25.

    Prognostic importance of change in QRS duration over time associated with left ventricular dysfunction in patients with congestive heart failure: the DIAMOND study.

    Fosbøl EL, Seibaek M, Brendorp B, Torp-Pedersen C, Køber L; Danish Investigations and Arrhythmia on Dofetilide (Diamond) Study Group.

    J Card Fail. 2008 Dec;14(10):850-5. Epub 2008 Sep 6.PMID: 19041049 [PubMed - indexed for MEDLINE]Related articles

    26.

    Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

    Maggioni AP, Caterson I, Coutinho W, Finer N, Gaal LV, Sharma AM, Torp-Pedersen C, Bacher P, Shepherd G, Sun R, James P; SCOUT Investigators.

    J Cardiovasc Pharmacol. 2008 Nov;52(5):393-402.PMID: 19033818 [PubMed - indexed for MEDLINE]Related articles

    27.

    Clinical trials update from the European Society of Cardiology congress in Munich, 2008: TIME-CHF, CARESS-in-AMI, TRITON-TIMI 38, EUROPA, AF-CHF, and ADVANCE.

    Horowitz J, Remme WJ, Torp-Pedersen C.

    Cardiovasc Drugs Ther. 2009 Feb;23(1):25-9. Epub 2008 Nov 19. No abstract available. PMID: 19016316 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Basic resuscitation of adults and automatic external defibrillation]

    Berlac PA, Torp-Pedersen CT, Lippert FK.

    Ugeskr Laeger. 2008 Nov 17;170(47):3855-7. Danish. PMID: 19014738 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Advanced resuscitation of adults]

    Lippert FK, Lauritsen TL, Torp-Pedersen C.

    Ugeskr Laeger. 2008 Nov 17;170(47):3848-51. Danish. PMID: 19014736 [PubMed - indexed for MEDLINE]Related articles

    30.

    Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations.

    Adiyaman A, Dechering DG, Boggia J, Li Y, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Thijs L, Torp-Pedersen C, Ohkubo T, Dolan E, Imai Y, Sandoya E, Ibsen H, Wang J, Lind L, O'Brien E, Thien T, Staessen JA; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators.

    Hypertension. 2008 Dec;52(6):1038-44. Epub 2008 Nov 10. Erratum in: Hypertension. 2009 Feb;53(2):e20. PMID: 19001188 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.

    Fosbøl EL, Gislason GH, Jacobsen S, Folke F, Hansen ML, Schramm TK, Sørensen R, Rasmussen JN, Andersen SS, Abildstrom SZ, Traerup J, Poulsen HE, Rasmussen S, Køber L, Torp-Pedersen C.

    Clin Pharmacol Ther. 2009 Feb;85(2):190-7. Epub 2008 Nov 5.PMID: 18987620 [PubMed - indexed for MEDLINE]Related articles

    32.

    Why epidemiological and clinical intervention studies often give different or diverging results?

    Poulsen HE, Andersen JT, Keiding N, Schramm TK, Sørensen R, Gislasson G, Fosbøl EL, Torp-Pedersen C.

    IUBMB Life. 2009 Apr;61(4):391-3. No abstract available. PMID: 18975376 [PubMed - indexed for MEDLINE]Related articles

    33.

    Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.

    Sørensen R, Gislason GH, Fosbøl EL, Rasmussen S, Køber L, Madsen JK, Torp-Pedersen C, Abildstrom SZ.

    Br J Clin Pharmacol. 2008 Dec;66(6):875-84. Epub 2008 Sep 23.PMID: 18823305 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Streptozotocin-induced diabetes decreases conducted vasoconstrictor response in mouse cremaster arterioles.

    Rai A, Riemann M, Gustafsson F, Holstein-Rathlou NH, Torp-Pedersen C.

    Horm Metab Res. 2008 Sep;40(9):651-4. Epub 2008 Sep 15.PMID: 18792878 [PubMed - indexed for MEDLINE]Related articles

    35.

    Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?

    Major-Pedersen A, Ihlemann N, Hermann TS, Christiansen B, Kveiborg B, Dominguez H, Nielsen D, Rask-Madsen C, Svendsen OL, Køber L, Torp-Pedersen C.

    Horm Metab Res. 2008 Sep;40(9):607-13. Epub 2008 Sep 15.PMID: 18792871 [PubMed - indexed for MEDLINE]Related articles

    36.

    New risk markers may change the HeartScore risk classification significantly in one-fifth of the population.

    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

    J Hum Hypertens. 2009 Feb;23(2):105-12. Epub 2008 Sep 11.PMID: 18784734 [PubMed - indexed for MEDLINE]Related articles

    37.

    C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.

    Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S.

    Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8.PMID: 18753952 [PubMed - indexed for MEDLINE]Related articles

    38.

    Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).

    Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedersen C, Bacher HP, Shepherd GM, James WP; SCOUT Investigators.

    Diabetes Obes Metab. 2009 Mar;11(3):239-50. Epub 2008 Jul 29.PMID: 18671798 [PubMed - indexed for MEDLINE]Related articles

    39.

    Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.

    Andersen SS, Hansen ML, Gislason GH, Folke F, Schramm TK, Fosbøl E, Sørensen R, Rasmussen S, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C.

    Cardiology. 2009;112(2):144-50. Epub 2008 Jul 9.PMID: 18612201 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prognostic importance of a short deceleration time in symptomatic congestive heart failure.

    Akkan D, Kjaergaard J, Møller JE, Hassager C, Torp-Pedersen C, Køber L; EchoCardiography and Heart Outcome Study (ECHOS) investigators.

    Eur J Heart Fail. 2008 Jul;10(7):689-95. Epub 2008 Jun 24.PMID: 18579440 [PubMed - indexed for MEDLINE]Related articles

    41.

    Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations.

    Hansen TW, Thijs L, Boggia J, Li Y, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Lind L, Sandoya E, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators.

    Hypertension. 2008 Aug;52(2):229-35. Epub 2008 Jun 23.PMID: 18574073 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Increased mortality after dronedarone therapy for severe heart failure.

    Køber L, Torp-Pedersen C, McMurray JJ, Gøtzsche O, Lévy S, Crijns H, Amlie J, Carlsen J; Dronedarone Study Group.

    N Engl J Med. 2008 Jun 19;358(25):2678-87.PMID: 18565860 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Wall motion index, estimated glomerular filtration rate and mortality risk in patients with heart failure or myocardial infarction: a pooled analysis of 18,010 patients.

    Schou M, Torp-Pedersen C, Gustafsson F, Abdulla J, Kober L.

    Eur J Heart Fail. 2008 Jul;10(7):682-8. Epub 2008 Jun 18.PMID: 18565790 [PubMed - indexed for MEDLINE]Related articles

    44.

    Accuracy of a heart failure diagnosis in administrative registers.

    Kümler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Køber L, Torp-Pedersen C.

    Eur J Heart Fail. 2008 Jul;10(7):658-60. Epub 2008 Jun 9.PMID: 18539522 [PubMed - indexed for MEDLINE]Related articles

    45.

    Chronic obstructive pulmonary disease in patients admitted with heart failure.

    Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E; ECHOS-Lung Function Study Group.

    J Intern Med. 2008 Oct;264(4):361-9. Epub 2008 Jun 5.PMID: 18537871 [PubMed - indexed for MEDLINE]Related articles

    46.

    Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.

    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

    J Hum Hypertens. 2008 Sep;22(9):634-40. Epub 2008 Jun 5.PMID: 18528412 [PubMed - indexed for MEDLINE]Related articles

    47.

    Is blood pressure during the night more predictive of cardiovascular outcome than during the day?

    Li Y, Boggia J, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'brien E, Staessen JA; International Database on Ambulatory Blood Pressure Monitoring in relation to Cardiovascular Outcomes Investigators.

    Blood Press Monit. 2008 Jun;13(3):145-7.PMID: 18496289 [PubMed - indexed for MEDLINE]Related articles

    48.

    Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications.

    Hansen TW, Kikuya M, Thijs L, Li Y, Boggia J, Björklund-Bodegârd K, Torp-Pedersen C, Jeppesen J, Ibsen H, Staessen JA.

    J Clin Hypertens (Greenwich). 2008 May;10(5):377-81. Review.PMID: 18453797 [PubMed - indexed for MEDLINE]Related articles

    49.

    The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.

    Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sørensen R, Rasmussen JN, Køber L, Madsen M, Torp-Pedersen C.

    Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):822-33.PMID: 18383428 [PubMed - indexed for MEDLINE]Related articles

    50.

    Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

    Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.

    Circulation. 2008 Apr 15;117(15):1945-54. Epub 2008 Mar 31.PMID: 18378618 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...